Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.46 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL315271 | 0.89 | ALDH1A1 (0.74) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| SCHEMBL21385010 | 0.86 | ALDH1A1 (0.52) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| Ammonia Solution, Strong SCHEMBL9807764 | 0.86 | ALDH1A1 (0.70) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| Acetic Acid SCHEMBL27535337 | 0.83 | ALDH1A1 (0.67) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| SCHEMBL2252807 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| SCHEMBL11223359 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| Acetic Acid Butyl Ester SCHEMBL11120658 | 0.83 | ALDH1A1 (0.82) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| SCHEMBL189930 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| SCHEMBL8619437 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CHRM5CHRM1CHRM3TSHR | |
| Acetic Acid Butyl Ester SCHEMBL20942936 | 0.81 | ALDH1A1 (0.78) | ALDH1A1CHRM5CHRM1CHRM3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2181979-B1 | Conversion of a multihydroxylated aliphatic hydrocarbon or ester thereof to a chlorohydrin | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-22 | — | — | EP | disclosed |
| EP-2174925-B1 | Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-10-15 | — | — | EP | disclosed |
| US-8404905-B2 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloroacetone levels | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-03-26 | — | — | US | disclosed |
| US-8304563-B2 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloroacetone levels | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-11-06 | — | — | US | disclosed |
| US-8236975-B2 | Process for the conversion of a crude glycerol, crude mixtures of naturally derived multicomponent aliphatic hydrocarbons or esters thereof to a chlorohydrin | DOW GLOBAL TECHNOLOGIES LLC | 2012-08-07 | — | — | US | disclosed |
| US-8088957-B2 | Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin | DOW GLOBAL TECHNOLOGIES LLC | 2012-01-03 | — | — | US | disclosed |
| US-20110178315-A1 | PROCESS FOR THE CONVERSION OF A CRUDE GLYCEROL, CRUDE MIXTURES OF NATURALLY DERIVED MULTICOMPONENT ALIPHATIC HYDROCARBONS OR ESTERS THEREOF TO A CHLOROHYDRIN | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-07-21 | — | — | US | disclosed |
| US-20110124890-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | BLUE CUBE IP LLC | 2011-05-26 | — | — | US | disclosed |
| US-20110124892-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | BLUE CUBE IP LLC | 2011-05-26 | — | — | US | disclosed |
| US-7910781-B2 | Process for the conversion of a crude glycerol, crude mixtures of naturally derived multihydroxylated aliphatic hydrocarbons or esters thereof to a chlorohydrin | DOW GLOBAL TECHNOLOGIES LLC | 2011-03-22 | — | — | US | disclosed |
| US-7906690-B2 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | DOW GLOBAL TECHNOLOGIES INC. | 2011-03-15 | — | — | US | disclosed |
| EP-2181979-A1 | Conversion of a multihydroxylated aliphatic hydrocarbon or ester thereof to a chlorohydrin | Dow Global Technologies Inc. (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-2174925-A1 | Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin | Dow Global Technologies Inc. (US) | 2010-04-14 | — | — | EP | disclosed |
| EP-1771403-B1 | CONVERSION OF A MULTIHYDROXYLATED-ALIPHATIC HYDROCARBON OR ESTER THEREOF TO A CHLOROHYDRIN | DOW GLOBAL TECHNOLOGIES INC (US) | 2010-01-06 | — | — | EP | disclosed |
| US-20080045728-A1 | Conversion of a Multihydroxylated-Aliphatic Hydrocarbon or Ester Thereof to a Chlorohydrin | BLUE CUBE IP LLC | 2008-02-21 | — | — | US | disclosed |
| US-20080015370-A1 | Process for the conversion of a crude glycerol, crude mixtures of naturally derived multicomponent aliphatic hydrocarbons or esters thereof to a chlorohydrin | BLUE CUBE IP LLC | 2008-01-17 | — | — | US | disclosed |
| US-20080015369-A1 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | BLUE CUBE IP LLC | 2008-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124892-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | GK, CHLSN, GLI2 | ALDH1A1 613/4885CHRM5 2998/4885CHRM1 3041/4885 |
| US-20080015370-A1 | Process for the conversion of a crude glycerol, crude mixtures of naturally derived multicomponent aliphatic hydrocarbons or esters thereof to a chlorohydrin | GK, CETP, CYP46A1 | ALDH1A1 1721/4885CHRM5 3633/4885CHRM1 4027/4885 |
| US-20080045728-A1 | Conversion of a Multihydroxylated-Aliphatic Hydrocarbon or Ester Thereof to a Chlorohydrin | CHN2, HDHD5, ASPH | ALDH1A1 2449/4885CHRM5 4240/4885CHRM1 4509/4885 |
| US-20110178315-A1 | PROCESS FOR THE CONVERSION OF A CRUDE GLYCEROL, CRUDE MIXTURES OF NATURALLY DERIVED MULTICOMPONENT ALIPHATIC HYDROCARBONS OR ESTERS THEREOF TO A CHLOROHYDRIN | GK, CETP, CYP46A1 | ALDH1A1 1721/4885CHRM5 3633/4885CHRM1 4027/4885 |
| US-20110124890-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | GK, CHLSN, GLI2 | ALDH1A1 613/4885CHRM5 2998/4885CHRM1 3041/4885 |
| US-20080015369-A1 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | GK, GLI2, CHLSN | ALDH1A1 701/4885CHRM5 2583/4885CHRM1 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.